Purchase Short-Term Access

Irbesartan reduced progression of nephropathy caused by type 2 diabetes independent of the effect on blood pressure

Christian G. Rabbat, MD

Annals of Internal Medicine 2002;136:83. doi:10.7326/ACPJC-2002-136-3-083

Purchase Online access to this article for 24 hours

Annals of Internal Medicine

Forgot Your Password?

to gain full access to the content and tools.

Learn more about subscription options

Forgot your password?

Enter your username and email address. We'll send you a reminder to the email address on record.

Username* (Required)

Email Address* (Required)